Cdc7-IN-5
CAT:
804-HY-130517-03
Size:
50 mg
Price:
Ask
- Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
- Dry Ice Shipment: No
Cdc7-IN-5
- CAS Number: 1402057-86-6
- UNSPSC Description: Cdc7-IN-5 (compound I-B) is a potent Cdc7 kinase inhibitor extracted from patent WO2019165473A1, compound I-B. Cdc7 is a serine-threonine protein kinase enzyme which is essential for the initiation of DNA replication in the cell cycle[1].
- Target Antigen: CDK
- Type: Reference compound
- Related Pathways: Cell Cycle/DNA Damage
- Field of Research: Cancer
- Assay Protocol: https://www.medchemexpress.com/cdc7-in-5.html
- Purity: 96.73
- Solubility: DMSO : 12.5 mg/mL (ultrasonic;warming;heat to 60°C)
- Smiles: O=C(C(C/1=O)=C(N2CC3=C(C=CC(OC)=C3)CC2)OC1=C/C4=CNC5=NC=CC=C54)OCC
- Molecular Weight: 445.47
- References & Citations: [1]Christian Andrew HASSIG, et al. Methods of treatment of cancer comprising cdc7 inhibitors. WO2019165473A1.
- Shipping Conditions: Room Temperature
- Storage Conditions: -20°C, 3 years; 4°C, 2 years (Powder)
- Clinical Information: No Development Reported